KORU Medical Systems, Inc.
KRMDNasdaq
$4.11
↓ -3.1%Jul 17 close · end-of-day
Price
1Y↑ +31.3%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$190.6M
Enterprise Value
$181.8M
P/E
—
P/S
4.4
P/B
11.3
EV/EBITDA
—
PEG
—
FCF Yield
—
Dividend Yield
—
Revenue (TTM)
$43.3M
Net Income (TTM)
-$2.3M
Free Cash Flow (TTM)
—
Gross Margin
61.9%
Operating Margin
-6.0%
Net Margin
-5.3%
ROE
-13.5%
ROIC
-25.1%
Debt / Equity
—
Net Cash
$8.8M
Return 1Y
+24.6%
Company profile
Repro Med Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. The company also provides education and training materials to clinicians, patients, and patient advocates.
- CEO
- Linda M. Tharby
- Sector
- Manufacturing
- Industry
- Medical Equipment
- Employees
- 80
- Headquarters
- New Jersey
- Website
- korumedical.com
Management & directors
- Kalbermatten Adam RPresident-Chief Commercial Off
- Schiller EricChief Technology Officer
- Tharby Linda MChief Executive Officer
- Adams Thomas EdwardChief Financial Officer
- Pazdan ChristopherChief Operating Officer
Roles derived from SEC Form 4 filings.
Earnings
KRMD Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$11.8M↑ +22.1%
Diluted EPS-$0.02↓ -33.3%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $24.2M | $23.5M | $27.9M | $28.5M | $33.6M | $41.1M |
| Gross profit | $14.9M | $13.8M | $15.4M | $16.7M | $21.3M | $25.6M |
| Operating income | -$1.3M | -$7.0M | -$10.8M | -$10.3M | -$6.4M | -$3.0M |
| Net income | -$1.2M | -$4.6M | -$8.7M | -$13.7M | -$6.1M | -$2.6M |
| Diluted EPS | -$0.03 | -$0.10 | -$0.19 | -$0.30 | -$0.13 | -$0.06 |
| Operating cash flow | -$743,323.00 | -$4.3M | -$5.4M | -$4.9M | -$319,718.00 | $462,405.00 |
| Free cash flow | — | — | — | — | — | — |
| Gross margin | 61.8% | 58.6% | 55.1% | 58.6% | 63.4% | 62.3% |
| Operating margin | -5.2% | -29.9% | -38.6% | -36.0% | -19.2% | -7.2% |
| Net margin | -5.0% | -19.4% | -31.0% | -48.2% | -18.0% | -6.4% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $8.4M | $8.2M | $8.8M | $9.6M | $10.2M | $10.4M | $10.9M | $11.8M |
| Gross profit | $5.5M | $5.2M | $5.6M | $6.0M | $6.5M | $6.3M | $6.8M | $7.2M |
| Operating income | -$1.2M | -$1.7M | -$1.6M | -$1.2M | -$312,655.00 | -$867,679.00 | -$547,103.00 | -$864,923.00 |
| Net income | -$988,715.00 | -$1.6M | -$1.6M | -$1.2M | -$206,867.00 | -$777,966.00 | -$486,856.00 | -$807,078.00 |
| Diluted EPS | $0.02 | $0.03 | -$0.22 | -$0.03 | $0.00 | $0.02 | -$0.05 | -$0.02 |
| Operating cash flow | $11,335.00 | -$923,948.00 | $939,615.00 | -$237,467.00 | -$460,340.00 | $65,456.00 | $1.1M | $14,663.00 |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | 65.0% | 63.4% | 62.9% | 62.8% | 63.5% | 60.2% | 62.6% | 61.5% |
| Operating margin | -14.1% | -20.8% | -18.0% | -12.9% | -3.1% | -8.3% | -5.0% | -7.4% |
| Net margin | -11.7% | -19.3% | -17.7% | -12.1% | -2.0% | -7.5% | -4.5% | -6.9% |
Company news
May 7, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-01 | FLETCHER R JOHN | Award | 5,357 | $4.20 | $22,499.40 | filing |
| 2026-07-01 | French Donna | Award | 3,571 | $4.20 | $14,998.20 | filing |
| 2026-07-01 | WHOLIHAN EDWARD | Award | 3,571 | $4.20 | $14,998.20 | filing |
| 2026-07-01 | CASCELLA ROBERT | Award | 3,571 | $4.20 | $14,998.20 | filing |
| 2026-07-01 | Matin Shahriar | Award | 3,571 | $4.20 | $14,998.20 | filing |
| 2026-06-30 | Manko Joseph M. Jr. | Award | 3,571 | $0.00 | $0.00 | filing |
| 2026-06-11 | KALBERMATTEN ADAM R· President-Chief Commercial Off | Buy | 7,500 | $3.93 | $29,475.00 | filing |
| 2026-06-11 | KALBERMATTEN ADAM R· President-Chief Commercial Off | Buy | 5,000 | $3.96 | $19,800.00 | filing |
| 2026-05-18 | Schiller Eric· Chief Technology Officer | Buy | 5,000 | $3.91 | $19,562.50 | filing |
| 2026-05-15 | Tharby Linda M· Chief Executive Officer | Buy | 1,191 | $1,191.00 | $1.4M | filing |
| 2026-05-15 | Tharby Linda M· Chief Executive Officer | Buy | 1,191 | $3.92 | $4,668.72 | filing |
| 2026-05-14 | Tharby Linda M· Chief Executive Officer | Tax withholding | 7,326 | $3.94 | $28,864.44 | filing |
| 2026-05-14 | Adams Thomas Edward· Chief Financial Officer | Buy | 5,041 | $3.86 | $19,458.26 | filing |
| 2026-05-14 | Pazdan Christopher· Chief Operating Officer | Buy | 5,000 | $3.88 | $19,400.00 | filing |
| 2026-05-14 | Adams Thomas Edward· Chief Financial Officer | Tax withholding | 2,900 | $3.94 | $11,426.00 | filing |
| 2026-05-14 | Pazdan Christopher· Chief Operating Officer | Tax withholding | 1,470 | $3.94 | $5,791.80 | filing |
| 2026-05-14 | Adams Thomas Edward· Chief Financial Officer | Buy | 459 | $3.90 | $1,790.10 | filing |
| 2026-05-14 | Pazdan Christopher· Chief Operating Officer | Option exercise | 5,327 | $0.00 | $0.00 | filing |
| 2026-05-14 | Tharby Linda M· Chief Executive Officer | Option exercise | 13,977 | $0.00 | $0.00 | filing |
| 2026-05-14 | Adams Thomas Edward· Chief Financial Officer | Option exercise | 8,193 | $0.00 | $0.00 | filing |
| 2026-04-01 | FLETCHER R JOHN | Award | 5,208 | $4.32 | $22,498.56 | filing |
| 2026-04-01 | French Donna | Award | 3,472 | $4.32 | $14,999.04 | filing |
| 2026-04-01 | WHOLIHAN EDWARD | Award | 3,472 | $4.32 | $14,999.04 | filing |
| 2026-04-01 | Matin Shahriar | Award | 3,472 | $4.32 | $14,999.04 | filing |
| 2026-04-01 | CASCELLA ROBERT | Award | 3,472 | $4.32 | $14,999.04 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.